Andreas Beilken

866 total citations
21 papers, 454 citations indexed

About

Andreas Beilken is a scholar working on Oncology, Infectious Diseases and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Andreas Beilken has authored 21 papers receiving a total of 454 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Oncology, 5 papers in Infectious Diseases and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Andreas Beilken's work include Neuroblastoma Research and Treatments (4 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Neutropenia and Cancer Infections (3 papers). Andreas Beilken is often cited by papers focused on Neuroblastoma Research and Treatments (4 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Neutropenia and Cancer Infections (3 papers). Andreas Beilken collaborates with scholars based in Germany, Austria and Switzerland. Andreas Beilken's co-authors include Karl‐Walter Sykora, Lorenz Grigull, Karl Welte, Hansjörg Schmid, Kathrin Seidemann, Christin Linderkamp, Annette Sander, Hans‐Gert Heuft, Lilia Goudeva and Albert Heim and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and Blood.

In The Last Decade

Andreas Beilken

21 papers receiving 442 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Andreas Beilken Germany	12	141	118	112	112	81	21	454
Satya Prakash Yadav India	12	134 1.0×	177 1.5×	93 0.8×	51 0.5×	155 1.9×	98	627
Ömer Devecioğlu Türkiye	14	69 0.5×	66 0.6×	116 1.0×	57 0.5×	164 2.0×	59	482
Elif Karakoç-Aydıner Türkiye	18	92 0.7×	69 0.6×	41 0.4×	183 1.6×	85 1.0×	72	900
Christin Linderkamp Germany	13	78 0.6×	70 0.6×	86 0.8×	50 0.4×	58 0.7×	20	345
Masateru Kawabata Japan	15	160 1.1×	95 0.8×	114 1.0×	22 0.2×	81 1.0×	39	567
Kelly Walkovich United States	13	50 0.4×	65 0.6×	120 1.1×	135 1.2×	65 0.8×	51	381
Dona Fleishaker United States	13	79 0.6×	140 1.2×	99 0.9×	66 0.6×	307 3.8×	28	906
A Oakhill United Kingdom	12	210 1.5×	80 0.7×	115 1.0×	169 1.5×	283 3.5×	21	590
E. Boesen United Kingdom	10	101 0.7×	111 0.9×	153 1.4×	79 0.7×	55 0.7×	16	533
Draga Barbaric Australia	14	90 0.6×	49 0.4×	91 0.8×	37 0.3×	201 2.5×	27	522

Countries citing papers authored by Andreas Beilken

Since Specialization

Citations

This map shows the geographic impact of Andreas Beilken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Andreas Beilken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Andreas Beilken more than expected).

Fields of papers citing papers by Andreas Beilken

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Andreas Beilken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Andreas Beilken. The network helps show where Andreas Beilken may publish in the future.

Co-authorship network of co-authors of Andreas Beilken

This figure shows the co-authorship network connecting the top 25 collaborators of Andreas Beilken. A scholar is included among the top collaborators of Andreas Beilken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Andreas Beilken. Andreas Beilken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Bielack, Stefan, Daniel Baumhoer, Andreas Beilken, et al.. (2025). Teleangiectatic Osteosarcoma Treated by Surgery and Chemotherapy: A Report of 223 Affected Patients From the Cooperative Osteosarcoma Study Group ( COSS ). Cancer Medicine. 14(17). e71211–e71211. 1 indexed citations

Corbacioglu, Selim, Holger N. Lode, Meinolf Suttorp, et al.. (2023). Irinotecan and temozolomide combined with dasatinib and rapamycin for patients with relapsed or refractory neuroblastoma: Results of the prospective randomized RIST trial.. Journal of Clinical Oncology. 41(16_suppl). 10001–10001. 1 indexed citations

Tilburg, Cornelis M. van, Ingrid Øra, Andreas Beilken, et al.. (2022). Phase I results of the INFORM2 combination study of nivolumab and entinostat in children and adolescents: INFORM2 NivEnt.. Journal of Clinical Oncology. 40(16_suppl). 10034–10034. 1 indexed citations

Fleischhack, Gudrun, Maura Massimino, Monika Warmuth‐Metz, et al.. (2019). Nimotuzumab and radiotherapy for treatment of newly diagnosed diffuse intrinsic pontine glioma (DIPG): a phase III clinical study. Journal of Neuro-Oncology. 143(1). 107–113. 30 indexed citations

Greiner, Jeanette, Martin Schrappe, Alexander Claviez, et al.. (2018). THROMBOTECT – a randomized study comparing low molecular weight heparin, antithrombin and unfractionated heparin for thromboprophylaxis during induction therapy of acute lymphoblastic leukemia in children and adolescents. Haematologica. 104(4). 756–765. 75 indexed citations

Baier, Claas, Sibylle Haid, Andreas Beilken, et al.. (2018). Molecular characteristics and successful management of a respiratory syncytial virus outbreak among pediatric patients with hemato-oncological disease. Antimicrobial Resistance and Infection Control. 7(1). 21–21. 4 indexed citations

Baier, Claas, Christin Linderkamp, Andreas Beilken, et al.. (2018). Influenza and respiratory syncytial virus screening for the detection of asymptomatically infected patients in hematology and oncology. SHILAP Revista de lepidopterología. 13. Doc08–Doc08. 13 indexed citations

Karremann, Michael, Marion Hoffmann, Maria Wiese, et al.. (2017). Haematological malignancies following temozolomide treatment for paediatric high-grade glioma. European Journal of Cancer. 81. 1–8. 4 indexed citations

Grünwald, Viktor, Florian Länger, Hans‐Juergen Raatschen, & Andreas Beilken. (2016). Proof of principle for bevacizumab activity in desmoid-type fibromatosis. PubMed. 6(1). 5–5. 3 indexed citations

10.

Wimmer, Katharina, Andreas Beilken, R. Nustede, et al.. (2016). A novel germline POLE mutation causes an early onset cancer prone syndrome mimicking constitutional mismatch repair deficiency. Familial Cancer. 16(1). 67–71. 50 indexed citations

11.

Bochennek, Konrad, Tobias M. Dantonello, Ewa Kościelniak, et al.. (2013). Response of Children with Stage IV Soft Tissue Sarcoma to Topotecan and Carboplatin: A Phase II Window Trial of the Cooperative Soft Tissue Sarcoma Group. Klinische Pädiatrie. 225(6). 309–314. 9 indexed citations

12.

Grigull, Lorenz, Karl‐Walter Sykora, Harald Bertram, et al.. (2011). Variable disease progression after successful stem cell transplantation: Prospective follow‐up investigations in eight patients with Hurler syndrome. Pediatric Transplantation. 15(8). 861–869. 17 indexed citations

13.

Sauer, Martin G., Barbara Meissner, Bernd Gruhn, et al.. (2008). Allogeneic blood SCT for children with Hurler's syndrome: results from the German multicenter approach MPS-HCT 2005. Bone Marrow Transplantation. 43(5). 375–381. 15 indexed citations

14.

Grigull, Lorenz, Lilia Goudeva, Karl‐Walter Sykora, et al.. (2006). G-CSF mobilised granulocyte transfusions in 32 paediatric patients with neutropenic sepsis. Supportive Care in Cancer. 14(9). 910–916. 45 indexed citations

15.

Grigull, Lorenz, Andreas Beilken, Annette Sander, et al.. (2006). Intravenous and oral sequential itraconazole antifungal prophylaxis in paediatric stem cell transplantation recipients: A pilot study for evaluation of safety and efficacy. Pediatric Transplantation. 11(3). 261–266. 27 indexed citations

16.

Grigull, Lorenz, Andreas Beilken, Hansjörg Schmid, et al.. (2006). Secondary prophylaxis of invasive fungal infections with combination antifungal therapy and G-CSF-mobilized granulocyte transfusions in three children with hematological malignancies. Supportive Care in Cancer. 14(7). 783–786. 40 indexed citations

17.

Grigull, Lorenz, Christin Linderkamp, Annette Sander, et al.. (2005). Multiple Spleen and Liver Abscesses Due to Yersinia enterocolitica Septicemia in a Child With Congenital Sideroblastic Anemia. Journal of Pediatric Hematology/Oncology. 27(11). 624–626. 8 indexed citations

18.

Sauer, Martin G., Melchior Lauten, Arnab Ghosh, et al.. (2005). Complete substitution of cyclophosphamide by fludarabine and ATG in a busulfan-based preparative regimen for children and adolescents with β-thalassemia. Bone Marrow Transplantation. 36(5). 383–387. 7 indexed citations

19.

Grigull, Lorenz, Andreas Beilken, Martin Schrappe, et al.. (2004). Transplantation of allogeneic CD34-selected stem cells after fludarabine-based conditioning regimen for children with mucopolysaccharidosis 1H (M. Hurler). Bone Marrow Transplantation. 35(3). 265–269. 22 indexed citations

20.

Seidemann, Kathrin, Albert Heim, Eva‐Doreen Pfister, et al.. (2004). Monitoring of Adenovirus Infection in Pediatric Transplant Recipients by Quantitative PCR: Report of Six Cases and Review of the Literature. American Journal of Transplantation. 4(12). 2102–2108. 68 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact